Clinical Trial Update: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial of nivolumab plus ipilimumab in non-resectable soft tissue and bone sarcomas, with exploration across several sarcoma subtypes and inclusion of e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Chondrosarcoma
• Desmoplastic Small Round Cell Tumor
• Endometrial Carcinoma
• Ewing Sarcoma
• Gastrointestinal Stromal Tumor
• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Soft Tissue Sarcoma, Bone Sarcoma | Phase 2 | Status: UNKNOWN